Global Companion Biomarker Market to Catapult to $319 Million by 2018
(firmenpresse) - NEW YORK, NY -- (Marketwired) -- 08/15/13 -- TriMarkPublications.com cites in its newly published " in Drug Development" report that the global market will catapult to $319 million by 2018. For more information, visit: .
can be categorized into four main therapeutic areas: oncology, cardiovascular, neurology and autoimmune. Oncology is the largest segment, commanding 30% of the market. Market opportunities for are focused in drug development targets, drug development efficacy and clinical end points. Using , the $883 billion global pharmaceutical market yields safer and more efficacious drug products, reduces clinical trial and development costs, improves post-marketing safety profiles and salvages therapies that otherwise would not be granted approval.
The " in Drug Development" report covers:
DNA Microarrays
Antibody Microarrays
Peptide Microarrays
Peptide MHC Microarrays
Tissue Microarrays
GeneChip Probe Array Technology
Multiple Reaction Monitoring Assays (MRMs)
C-KIT (CD117) Expression
CYP2C19 Variants
CYP2C9 Variants
CYP2D6 Variants
Kidney Toxicity
Hepatotoxicity
The " in Drug Development" report examines companies manufacturing equipment and supplies in the world. Companies covered include: Abbott, Accelrys, Almac, Ananomouse, ArrayIt, AstraZeneca, Axontologic, BD, Bioalma, BioCat, BioData, Biodesix, BioForce Nanosciences, BioGenex, BioMérieux, Bio-Rad, Biotrin, BioWisdom, Caliper Life, Caprion Proteomics, Cepheid, Clontech, Corimbia, Covance, CyVera, Dako, DiagnoSwiss, DNAStar, Eli Lilly, ePitope Informatics, Eurogentec, Fujitsu, GEcare, Gene Network, Genedata, GeneStudio, Geneva Bioinformatics, GenomeQuest, Genomining, Genzyme, Geospiza, Golden Helix, Grace Bio-Labs, High Throughput, Imgenex, INCOGEN, InforSense, Ingenuity, Integromics, Ipsen, Koada Technology, KOOPrime, LINCO, Luminex, MDS, Meso Scale Discovery, MicroDiscovery, Millennium, MiraiBio, Molecular Connections, Monograms, Multimetrix, NetGenics, NextGen, Nonlinear Dynamics, Novartis, Osmetech, Oxonica, Panomics, Partek, Perlegen, PharmaSeq, Predictive Patterns, Proceryon, ProteinOne, Proteome, Radix BioSolutions, RayBiotech, Reel Two, Rescentris, Rosetta Biosoftware, SAS, Semantx Life, Softberry, SoftGenetics, Spotfire, SPSS, Sun Microsystems, SurroMed, Tepnel, Teranode, TG Services, Thermo Fisher, TimeLogic, Tyrian, ViaLogy, Wyeth, Zeus and Zyagen.
Detailed charts with sales forecasts and marketshare data are included. For more information, visit: .
TriMarkPublications.com is a global leader in the biotechnology, healthcare and life sciences market research publishing. For more information, please visit .
The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.
TriMarkPublications.com
Media Relations
1-888-OK-TRIMARK
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 15.08.2013 - 17:45 Uhr
Sprache: Deutsch
News-ID 288315
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY
Kategorie:
Commercial & Investment Banking
Diese Pressemitteilung wurde bisher 205 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Global Companion Biomarker Market to Catapult to $319 Million by 2018"
steht unter der journalistisch-redaktionellen Verantwortung von
TriMarkPublications.com (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
